{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:23:39Z","timestamp":1790868219247,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Peroxisome proliferator-activated receptor <jats:italic>\u03b3<\/jats:italic> (PPAR<jats:italic>\u03b3<\/jats:italic>) has been shown to be a therapeutic target for preeclampsia (PE). Angiopoietin-like protein 4 (ANGPTL4) is a multifunctional secretory protein involved in regulating lipid metabolism and angiogenesis in various tissues. However, the expression of PPAR<jats:italic>\u03b3<\/jats:italic> and ANGPTL4 and their interaction in PE remain elusive. Here we showed that PPAR<jats:italic>\u03b3<\/jats:italic> agonist rosiglitazone upregulated the expression and secretion of ANGPTL4 in a dose-dependent manner in HTR8\/SVneo cells, human umbilical vein endothelial cells (HUVECs) and placental explants. More importantly, we confirmed that the PPAR<jats:italic>\u03b3<\/jats:italic>\/retinoid X receptor <jats:italic>\u03b1<\/jats:italic> heterodimer specifically binds to the ANGPTL4 promoter region and enhances its transcriptional activity. In addition, the levels of ANGPTL4 and PPAR<jats:italic>\u03b3<\/jats:italic> activators in the serum and their expression in placental tissues were significantly reduced in preeclamptic patients compared with normal pregnant subjects. Furthermore, functional studies demonstrated that ANGPTL4 mediates the facilitative effects of the PPAR<jats:italic>\u03b3<\/jats:italic> agonist on the survival, proliferation, migration and invasion of HTR8\/SVneo cells, placental explants outgrowth and angiogenesis in HUVECs. Taken together, our results suggest that ANGPTL4 is a potential target gene for PPAR<jats:italic>\u03b3<\/jats:italic> and mediates the protective role of PPAR<jats:italic>\u03b3<\/jats:italic> activators in the pathogenesis of PE.<\/jats:p>","DOI":"10.1038\/cddis.2017.419","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T12:40:59Z","timestamp":1505997659000},"page":"e3054-e3054","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["ANGPTL4 mediates the protective role of PPAR\u03b3 activators in the pathogenesis of preeclampsia"],"prefix":"10.1038","volume":"8","author":[{"given":"Lei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,21]]},"reference":[{"key":"BFcddis2017419_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"376","author":"EA Steegers","year":"2010","unstructured":"Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R . Pre-eclampsia. Lancet 2010; 376: 631\u2013644.","journal-title":"Lancet"},{"key":"BFcddis2017419_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1210\/en.2013-1350","volume":"155","author":"P He","year":"2014","unstructured":"He P, Chen Z, Sun Q, Li Y, Gu H, Ni X . Reduced expression of 11beta-hydroxysteroid dehydrogenase type 2 in preeclamptic placentas is associated with decreased PPARgamma but increased PPARalpha expression. Endocrinology 2014; 155: 299\u2013309.","journal-title":"Endocrinology"},{"key":"BFcddis2017419_CR3","doi-asserted-by":"publisher","first-page":"E1370","DOI":"10.1210\/jc.2011-2729","volume":"97","author":"L Yu","year":"2012","unstructured":"Yu L, Li D, Liao QP, Yang HX, Cao B, Fu G et al. High levels of activin A detected in preeclamptic placenta induce trophoblast cell apoptosis by promoting nodal signaling. J Clin Endocrinol Metab 2012; 97: E1370\u2013E1379.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFcddis2017419_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K et al. The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835\u2013839.","journal-title":"Cell"},{"key":"BFcddis2017419_CR5","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/STROKEAHA.109.576942","volume":"41","author":"MJ Cipolla","year":"2010","unstructured":"Cipolla MJ, Bishop N, Vinke RS, Godfrey JA . PPAR{gamma} activation prevents hypertensive remodeling of cerebral arteries and improves vascular function in female rats. Stroke 2010; 41: 1266\u20131270.","journal-title":"Stroke"},{"key":"BFcddis2017419_CR6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/01.ATV.19.3.546","volume":"19","author":"N Marx","year":"1999","unstructured":"Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J . PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol 1999; 19: 546\u2013551.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFcddis2017419_CR7","first-page":"3874","volume":"85","author":"WT Schaiff","year":"2000","unstructured":"Schaiff WT, Carlson MG, Smith SD, Levy R, Nelson DM, Sadovsky Y . Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner. J Clin Endocrinol Metab 2000; 85: 3874\u20133881.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFcddis2017419_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1210\/jc.2004-0849","volume":"90","author":"LL Waite","year":"2005","unstructured":"Waite LL, Louie RE, Taylor RN . Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab 2005; 90: 620\u2013626.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFcddis2017419_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/HYPERTENSIONAHA.111.172627","volume":"58","author":"FP McCarthy","year":"2011","unstructured":"McCarthy FP, Drewlo S, Kingdom J, Johns EJ, Walsh SK, Kenny LC . Peroxisome proliferator-activated receptor-gamma as a potential therapeutic target in the treatment of preeclampsia. Hypertension 2011; 58: 280\u2013286.","journal-title":"Hypertension"},{"key":"BFcddis2017419_CR10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/hep.24479","volume":"54","author":"H Li","year":"2011","unstructured":"Li H, Ge C, Zhao F, Yan M, Hu C, Jia D et al. Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1\/integrin beta1 signaling in human hepatocellular carcinoma. Hepatology 2011; 54: 910\u2013919.","journal-title":"Hepatology"},{"key":"BFcddis2017419_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.tcm.2007.10.003","volume":"18","author":"T Hato","year":"2008","unstructured":"Hato T, Tabata M, Oike Y . The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med 2008; 18: 6\u201314.","journal-title":"Trends Cardiovasc Med"},{"key":"BFcddis2017419_CR12","doi-asserted-by":"publisher","first-page":"32999","DOI":"10.1074\/jbc.M110.108175","volume":"285","author":"YY Goh","year":"2010","unstructured":"Goh YY, Pal M, Chong HC, Zhu P, Tan MJ, Punugu L et al. Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing. J Biol Chem 2010; 285: 32999\u201333009.","journal-title":"J Biol Chem"},{"key":"BFcddis2017419_CR13","doi-asserted-by":"publisher","first-page":"9236","DOI":"10.1158\/0008-5472.CAN-09-2067","volume":"69","author":"L Tian","year":"2009","unstructured":"Tian L, Zhou J, Casimiro MC, Liang B, Ojeifo JO, Wang M et al. Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis. Cancer Res 2009; 69: 9236\u20139244.","journal-title":"Cancer Res"},{"key":"BFcddis2017419_CR14","doi-asserted-by":"publisher","first-page":"15498","DOI":"10.1073\/pnas.1513872112","volume":"112","author":"D Ben-Zvi","year":"2015","unstructured":"Ben-Zvi D, Barrandon O, Hadley S, Blum B, Peterson QP, Melton DA . Angptl4 links alpha-cell proliferation following glucagon receptor inhibition with adipose tissue triglyceride metabolism. Proc Natl Acad Sci USA 2015; 112: 15498\u201315503.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2017419_CR15","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1136\/gut.2007.129858","volume":"56","author":"K Yamazaki","year":"2007","unstructured":"Yamazaki K, Shimizu M, Okuno M, Matsushima-Nishiwaki R, Kanemura N, Araki H et al. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells\u2014phosphorylated RXR alpha is a critical target for colon cancer management. Gut 2007; 56: 1557\u20131563.","journal-title":"Gut"},{"key":"BFcddis2017419_CR16","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1210\/jc.2004-2265","volume":"90","author":"WT Schaiff","year":"2005","unstructured":"Schaiff WT, Bildirici I, Cheong M, Chern PL, Nelson DM, Sadovsky Y . Peroxisome proliferator-activated receptor-gamma and retinoid X receptor signaling regulate fatty acid uptake by primary human placental trophoblasts. J Clin Endocrinol Metab 2005; 90: 4267\u20134275.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFcddis2017419_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/15548627.2015.1034414","volume":"11","author":"M Melland-Smith","year":"2015","unstructured":"Melland-Smith M, Ermini L, Chauvin S, Craig-Barnes H, Tagliaferro A, Todros T et al. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia. Autophagy 2015; 11: 653\u2013669.","journal-title":"Autophagy"},{"key":"BFcddis2017419_CR18","doi-asserted-by":"publisher","first-page":"E1056","DOI":"10.1152\/ajpendo.90345.2008","volume":"295","author":"O Gealekman","year":"2008","unstructured":"Gealekman O, Burkart A, Chouinard M, Nicoloro SM, Straubhaar J, Corvera S . Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. Am J Physiol Endocrinol Metab 2008; 295: E1056\u2013E1064.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFcddis2017419_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ajh.2007.39","volume":"21","author":"R Limor","year":"2008","unstructured":"Limor R, Sharon O, Knoll E, Many A, Weisinger G, Stern N . Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells. Am J Hypertens 2008; 21: 219\u2013223.","journal-title":"Am J Hypertens"},{"key":"BFcddis2017419_CR20","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.4049\/jimmunol.1400378","volume":"192","author":"E Frenzel","year":"2014","unstructured":"Frenzel E, Wrenger S, Immenschuh S, Koczulla R, Mahadeva R, Deeg HJ et al. Acute-phase protein alpha1-antitrypsin\u2014a novel regulator of angiopoietin-like protein 4 transcription and secretion. J Immunol 2014; 192: 5354\u20135362.","journal-title":"J Immunol"},{"key":"BFcddis2017419_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","volume":"4","author":"Y Barak","year":"1999","unstructured":"Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999; 4: 585\u2013595.","journal-title":"Mol Cell"},{"key":"BFcddis2017419_CR22","first-page":"5017","volume":"86","author":"A Tarrade","year":"2001","unstructured":"Tarrade A, Schoonjans K, Pavan L, Auwerx J, Rochette-Egly C, Evain-Brion D et al. PPARgamma\/RXRalpha heterodimers control human trophoblast invasion. J Clin Endocrinol Metab 2001; 86: 5017\u20135024.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFcddis2017419_CR23","first-page":"3808","volume":"85","author":"LL Waite","year":"2000","unstructured":"Waite LL, Person EC, Zhou Y, Lim KH, Scanlan TS, Taylor RN . Placental peroxisome proliferator-activated receptor-gamma is up-regulated by pregnancy serum. J Clin Endocrinol Metab 2000; 85: 3808\u20133814.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFcddis2017419_CR24","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.ajpath.2015.06.010","volume":"185","author":"FJ Tian","year":"2015","unstructured":"Tian FJ, Qin CM, Li XC, Wu F, Liu XR, Xu WM et al. Decreased stathmin-1 expression inhibits trophoblast proliferation and invasion and is associated with recurrent miscarriage. Am J Pathol 2015; 185: 2709\u20132721.","journal-title":"Am J Pathol"},{"key":"BFcddis2017419_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/jp.2014.136","volume":"35","author":"Y Yang","year":"2015","unstructured":"Yang Y, Zhang J, Gong Y, Liu X, Bai Y, Xu W et al. Increased expression of prostasin contributes to early-onset severe preeclampsia through inhibiting trophoblast invasion. J Perinatol 2015; 35: 16\u201322.","journal-title":"J Perinatol"},{"key":"BFcddis2017419_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1634\/theoncologist.9-suppl_1-2","volume":"9","author":"N Ferrara","year":"2004","unstructured":"Ferrara N . Vascular endothelial growth factor as a target for anticancer therapy. Oncologist 2004; 9: 2\u201310.","journal-title":"Oncologist"},{"key":"BFcddis2017419_CR27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/S0002-9378(98)70021-3","volume":"179","author":"DS Torry","year":"1998","unstructured":"Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ . Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998; 179: 1539\u20131544.","journal-title":"Am J Obstet Gynecol"},{"key":"BFcddis2017419_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3109\/01443615.2012.677875","volume":"32","author":"N Uras","year":"2012","unstructured":"Uras N, Oguz SS, Zergeroglu S, Akdag A, Polat B, Dizdar EA et al. CD31 and Factor VIII in angiogenesis of normal and pre-eclamptic human placentas. J Obstet Gynaecol 2012; 32: 533\u2013536.","journal-title":"J Obstet Gynaecol"},{"key":"BFcddis2017419_CR29","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1210\/en.2008-0456","volume":"150","author":"M Bilban","year":"2009","unstructured":"Bilban M, Haslinger P, Prast J, Klinglmuller F, Woelfel T, Haider S et al. Identification of novel trophoblast invasion-related genes: heme oxygenase-1 controls motility via peroxisome proliferator-activated receptor gamma. Endocrinology 2009; 150: 1000\u20131013.","journal-title":"Endocrinology"},{"key":"BFcddis2017419_CR30","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1210\/jc.2005-0413","volume":"90","author":"C Nicola","year":"2005","unstructured":"Nicola C, Timoshenko AV, Dixon SJ, Lala PK, Chakraborty C . EP1 receptor-mediated migration of the first trimester human extravillous trophoblast: the role of intracellular calcium and calpain. J Clin Endocrinol Metab 2005; 90: 4736\u20134746.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFcddis2017419_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bbrc.2015.04.061","volume":"461","author":"L Liu","year":"2015","unstructured":"Liu L, Zhang J, Fang C, Zhang Z, Feng Y, Xi X . OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1\/2 signaling pathway in epithelial ovarian cancer. Biochem Biophys Res Commun 2015; 461: 525\u2013532.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcddis2017419_CR32","doi-asserted-by":"publisher","first-page":"e1396","DOI":"10.1038\/cddis.2014.335","volume":"5","author":"S Liu","year":"2014","unstructured":"Liu S, Wang J, Qin HM, Yan XM, Yang XS, Liu C et al. LIF upregulates poFUT1 expression and promotes trophoblast cell migration and invasion at the fetal-maternal interface. Cell Death Dis 2014; 5: e1396.","journal-title":"Cell Death Dis"},{"key":"BFcddis2017419_CR33","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1210\/jc.2015-1606","volume":"100","author":"NA Liu","year":"2015","unstructured":"Liu NA, Araki T, Cuevas-Ramos D, Hong J, Ben-Shlomo A, Tone Y et al. Cyclin E-mediated human proopiomelanocortin regulation as a therapeutic target for cushing disease. J Clin Endocrinol Metab 2015; 100: 2557\u20132564.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFcddis2017419_CR34","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1242\/jcs.096412","volume":"125","author":"L Luo","year":"2012","unstructured":"Luo L, Ye G, Nadeem L, Fu G, Yang BB, Honarparvar E et al. MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal. J Cell Sci 2012; 125: 3124\u20133132.","journal-title":"J Cell Sci"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2017419.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017419","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cddis.2017.419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017419.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T18:19:31Z","timestamp":1671733171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2017419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,21]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9]]}},"alternative-id":["BFcddis2017419"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2017.419","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,21]]},"assertion":[{"value":"7 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}